Results 131 to 140 of about 7,850 (312)

ElixirSeeker: A Machine Learning Framework Utilizing Fusion Molecular Fingerprints for the Discovery of Lifespan‐Extending Compounds

Aging Cell, EarlyView.
ElixirSeeker is a machine learning architecture based on a phenotype‐driven drug discovery approach to screen lifespan‐extending compounds. By integrating molecular fingerprints, ElixirSeeker could maximize feature capture of lifespan‐extending compounds.
Yan Pan, Hongxia Cai, Fang Ye, Wentao Xu, Zhihang Huang, Jingyuan Zhu, Yiwen Gong, Yutong Li, Anastasia Ngozi Ezemaduka, Shan Gao, Shunqi Liu, Guojun Li, Hao Li, Jing Yang, Junyu Ning, Bo Xian   +15 more
wiley   +1 more source

Additional file 1 of Clinicopathological features of patients with wide local excision of eyelid malignant neoplasms: a more than five years retrospective study from China

, 2022
Yuanyuan Han, Miao Kong, Yan Luo, Bin Sun, Zhiqiang Wang, Hong Zhang   +5 more
openalex   +2 more sources

Eight‐Year Experience of Hedgehog Pathway Inhibitors at Three Tertiary Referral Centres in the Australian State of Victoria

Australasian Journal of Dermatology, EarlyView.
ABSTRACT This retrospective analysis of Hedgehog inhibitor treatment in 32 patients with Gorlin syndrome, locally advanced and metastatic basal cell carcinoma (BCC) at three tertiary referral centres in Victoria, Australia from April 2017 until 30 June 2024 demonstrated an 84% overall objective response rate (partial and complete response combined ...
Christian Gan, Nicholas Manuelpillai, Peter Foley, Christopher McCormack, Michelle S. Goh   +4 more
wiley   +1 more source

Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market

Acta Ophthalmologica, EarlyView.
Abstract Purpose To provide an overview of artificial tears marketed in the following Nordic countries: Denmark, Finland, Norway, Iceland and Sweden. Furthermore, this review aimed to highlight the different preservatives and other constituents found in artificial tears in the Nordic market, focussing on adverse effects.
K. N. Mikha, C. E. Ø. Rasmussen, S. N. G. Ahrensberg, J. Freiberg, R. A. Wozniak, U. M. K. Alnoor, F. Fineide, T. P. Utheim, S. Heegaard, M. Kolko   +9 more
wiley   +1 more source

Rhomboid blepharoplasty and cryotherapy for the treatment of a squamous cell carcinoma on the lower eyelid in a horse [PDF]

, 2018
Beard, Bellone, Blanchard, Bosch, Cutler, Dugan, Dugan, Esson, Gelatt, Gelatt, Giuliano, Giuliano, Harling, Hilbert, Kaps, King, Kübler, Lassaline, Lavach, Malalana, McCauley, Montgomery, Mosunic, Ng, Pavletic, Payne, Plummer, Rayner, Schoster, Schwink, Singer-Berk, Surjan, Theón, Theón, Walker, Walker, Wyn-Jones   +36 more
core   +1 more source

Ocular Neuromyotonia—A Rare but Reversible Cause of Intermittent Diplopia

Movement Disorders Clinical Practice, EarlyView.
Parthvi Ravat, Paul Stockle, Mahadya Rahman, Pegah Ahmadiyan Ardestani, Andrew Lee   +4 more
wiley   +1 more source

Aqueous humour concentrations of HB‐EGF, EGF and VEGF‐A and axial length in humans

Acta Ophthalmologica, EarlyView.
Abstract Purpose To investigate relationships between the intraocular concentrations of heparin‐binding epidermal growth factor (HB‐EGF), epidermal growth factor (EGF) and vascular endothelial growth factor A (VEGF‐A) in dependence on axial length in humans. Design Clinical interventional cohort study.
Wen‐Da Zhou, Li Dong, Yu‐Hang Yang, Yuan He, Xiao‐Zhen Wang, Han‐Qing Zhao, Rui‐Heng Zhang, Jost B. Jonas, Wen‐Bin Wei   +8 more
wiley   +1 more source

Porous polyethylene in reconstructive head and neck surgery [PDF]

, 1985
Berghaus, Alexander
core   +1 more source

THE PREVALENCE AND TREATMENT OF EYELID NEOPLASMS IN DOGS : 69 CASES (2000-2003)

, 2004
Nalinee Tuntivanich, Pranee Tuntivanich, Santi Wongaumnuaykul, Anudep Rungsipipat   +3 more
openalex   +2 more sources

Choroidal melanoma patient views on the importance of treatment characteristics and outcomes, and physicians' information provision in the Netherlands

Acta Ophthalmologica, EarlyView.
Abstract Purpose To identify the treatment characteristics and outcomes that Dutch patients with large or juxtapapillary choroidal melanoma consider important when choosing between enucleation and proton beam therapy (PBT). We further determined to what extent these treatment characteristics and outcomes are discussed with newly diagnosed choroidal ...
Aryana Shirzada, Arwen H. Pieterse, Lisa Vlug, Gré P. M. Luyten, T. H. Khanh Vu, Jaco C. Bleeker, Pauline A. Bakker, Marina Marinkovic, Coen R. N. Rasch, Nanda Horeweg, M. Elske van den Akker‐Van Marle   +10 more
wiley   +1 more source